I talked with Terry today. My question was, "What is the scope of the Abbott deal re: cancer diagnostics? Is the deal limited to just prostate? He forwarded that "?" to Dr. Moro, and the answer is, Abbott may use the technology for diagnosis of cancer across the board and is not limited to just the prostate. That is good news!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.